ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Long-acting Reversible Contraceptives (LARCs) Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-12N10753
Home | Market Reports | Health| Reproductive Health
Global Long acting Reversible Contraceptives LARCs Market Research Report 2022
BUY CHAPTERS

Global Long-acting Reversible Contraceptives (LARCs) Market Research Report 2025

Code: QYRE-Auto-12N10753
Report
March 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Merck
Cooper Companies
AbbVie(Allergan)
Yantai JiShengYaoXie
H & J Medical
HRA Pharma
Pregna
ASPIVIX
Shanghai Dahua Pharmaceuticals
Williams Medical Supplies
Laboratoire 7 MED
Durbin
Laboratoire Ccd
Prosan
OCON

Long-acting Reversible Contraceptives (LARCs) Market

The global market for Long-acting Reversible Contraceptives (LARCs) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Long-acting Reversible Contraceptives (LARCs) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Long-acting Reversible Contraceptives (LARCs) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Long-acting Reversible Contraceptives (LARCs) include Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical, HRA Pharma, Pregna, ASPIVIX, Shanghai Dahua Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Long-acting Reversible Contraceptives (LARCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting Reversible Contraceptives (LARCs).
The Long-acting Reversible Contraceptives (LARCs) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-acting Reversible Contraceptives (LARCs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-acting Reversible Contraceptives (LARCs) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Long-acting Reversible Contraceptives (LARCs) Market Report

Report Metric Details
Report Name Long-acting Reversible Contraceptives (LARCs) Market
Segment by Type
Segment by Application
  • Age 20-24
  • Age 25-34
  • Age 35-44
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical, HRA Pharma, Pregna, ASPIVIX, Shanghai Dahua Pharmaceuticals, Williams Medical Supplies, Laboratoire 7 MED, Durbin, Laboratoire CCD, Prosan, OCON
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Long-acting Reversible Contraceptives (LARCs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Long-acting Reversible Contraceptives (LARCs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Long-acting Reversible Contraceptives (LARCs) Market report?

Ans: The main players in the Long-acting Reversible Contraceptives (LARCs) Market are Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical, HRA Pharma, Pregna, ASPIVIX, Shanghai Dahua Pharmaceuticals, Williams Medical Supplies, Laboratoire 7 MED, Durbin, Laboratoire CCD, Prosan, OCON

What are the Application segmentation covered in the Long-acting Reversible Contraceptives (LARCs) Market report?

Ans: The Applications covered in the Long-acting Reversible Contraceptives (LARCs) Market report are Age 20-24, Age 25-34, Age 35-44, Others

What are the Type segmentation covered in the Long-acting Reversible Contraceptives (LARCs) Market report?

Ans: The Types covered in the Long-acting Reversible Contraceptives (LARCs) Market report are Hormonal Intrauterine Devices, Copper Intrauterine Devices, Contraceptive Implants, Others

Recommended Reports

Contraceptive Markets

Reproductive Health

Long-acting Therapies

1 Long-acting Reversible Contraceptives (LARCs) Market Overview
1.1 Product Definition
1.2 Long-acting Reversible Contraceptives (LARCs) by Type
1.2.1 Global Long-acting Reversible Contraceptives (LARCs) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hormonal Intrauterine Devices
1.2.3 Copper Intrauterine Devices
1.2.4 Contraceptive Implants
1.2.5 Others
1.3 Long-acting Reversible Contraceptives (LARCs) by Application
1.3.1 Global Long-acting Reversible Contraceptives (LARCs) Market Value by Application (2024 VS 2031)
1.3.2 Age 20-24
1.3.3 Age 25-34
1.3.4 Age 35-44
1.3.5 Others
1.4 Global Long-acting Reversible Contraceptives (LARCs) Market Size Estimates and Forecasts
1.4.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue 2020-2031
1.4.2 Global Long-acting Reversible Contraceptives (LARCs) Sales 2020-2031
1.4.3 Global Long-acting Reversible Contraceptives (LARCs) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Long-acting Reversible Contraceptives (LARCs) Market Competition by Manufacturers
2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Long-acting Reversible Contraceptives (LARCs) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Long-acting Reversible Contraceptives (LARCs), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Long-acting Reversible Contraceptives (LARCs), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Long-acting Reversible Contraceptives (LARCs), Product Type & Application
2.7 Global Key Manufacturers of Long-acting Reversible Contraceptives (LARCs), Date of Enter into This Industry
2.8 Global Long-acting Reversible Contraceptives (LARCs) Market Competitive Situation and Trends
2.8.1 Global Long-acting Reversible Contraceptives (LARCs) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Long-acting Reversible Contraceptives (LARCs) Players Market Share by Revenue
2.8.3 Global Long-acting Reversible Contraceptives (LARCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-acting Reversible Contraceptives (LARCs) Market Scenario by Region
3.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2020-2031
3.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2020-2025
3.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2026-2031
3.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2020-2031
3.3.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2020-2025
3.3.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2026-2031
3.4 North America Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
3.4.1 North America Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2020-2031)
3.4.3 North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
3.5.1 Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2020-2031)
3.5.3 Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Region
3.6.1 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2020-2031)
3.6.3 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
3.7.1 Latin America Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2020-2031)
3.7.3 Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2020-2031)
4.1.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2020-2025)
4.1.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2026-2031)
4.1.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2020-2031)
4.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2020-2031)
4.2.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2020-2025)
4.2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2026-2031)
4.2.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2020-2031)
4.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2020-2031)
5.1.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2020-2025)
5.1.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2026-2031)
5.1.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2020-2031)
5.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2020-2031)
5.2.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2020-2025)
5.2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2026-2031)
5.2.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2020-2031)
5.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Cooper Companies
6.3.1 Cooper Companies Company Information
6.3.2 Cooper Companies Description and Business Overview
6.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.3.5 Cooper Companies Recent Developments/Updates
6.4 AbbVie Allergan
6.4.1 AbbVie Allergan Company Information
6.4.2 AbbVie Allergan Description and Business Overview
6.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.4.5 AbbVie Allergan Recent Developments/Updates
6.5 Yantai JiShengYaoXie
6.5.1 Yantai JiShengYaoXie Company Information
6.5.2 Yantai JiShengYaoXie Description and Business Overview
6.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.5.5 Yantai JiShengYaoXie Recent Developments/Updates
6.6 H & J Medical
6.6.1 H & J Medical Company Information
6.6.2 H & J Medical Description and Business Overview
6.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.6.5 H & J Medical Recent Developments/Updates
6.7 HRA Pharma
6.7.1 HRA Pharma Company Information
6.7.2 HRA Pharma Description and Business Overview
6.7.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.7.5 HRA Pharma Recent Developments/Updates
6.8 Pregna
6.8.1 Pregna Company Information
6.8.2 Pregna Description and Business Overview
6.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.8.5 Pregna Recent Developments/Updates
6.9 ASPIVIX
6.9.1 ASPIVIX Company Information
6.9.2 ASPIVIX Description and Business Overview
6.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.9.5 ASPIVIX Recent Developments/Updates
6.10 Shanghai Dahua Pharmaceuticals
6.10.1 Shanghai Dahua Pharmaceuticals Company Information
6.10.2 Shanghai Dahua Pharmaceuticals Description and Business Overview
6.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.10.5 Shanghai Dahua Pharmaceuticals Recent Developments/Updates
6.11 Williams Medical Supplies
6.11.1 Williams Medical Supplies Company Information
6.11.2 Williams Medical Supplies Description and Business Overview
6.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.11.5 Williams Medical Supplies Recent Developments/Updates
6.12 Laboratoire 7 MED
6.12.1 Laboratoire 7 MED Company Information
6.12.2 Laboratoire 7 MED Description and Business Overview
6.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.12.5 Laboratoire 7 MED Recent Developments/Updates
6.13 Durbin
6.13.1 Durbin Company Information
6.13.2 Durbin Description and Business Overview
6.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.13.5 Durbin Recent Developments/Updates
6.14 Laboratoire CCD
6.14.1 Laboratoire CCD Company Information
6.14.2 Laboratoire CCD Description and Business Overview
6.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.14.5 Laboratoire CCD Recent Developments/Updates
6.15 Prosan
6.15.1 Prosan Company Information
6.15.2 Prosan Description and Business Overview
6.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.15.5 Prosan Recent Developments/Updates
6.16 OCON
6.16.1 OCON Company Information
6.16.2 OCON Description and Business Overview
6.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio
6.16.5 OCON Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-acting Reversible Contraceptives (LARCs) Industry Chain Analysis
7.2 Long-acting Reversible Contraceptives (LARCs) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-acting Reversible Contraceptives (LARCs) Production Mode & Process Analysis
7.4 Long-acting Reversible Contraceptives (LARCs) Sales and Marketing
7.4.1 Long-acting Reversible Contraceptives (LARCs) Sales Channels
7.4.2 Long-acting Reversible Contraceptives (LARCs) Distributors
7.5 Long-acting Reversible Contraceptives (LARCs) Customer Analysis
8 Long-acting Reversible Contraceptives (LARCs) Market Dynamics
8.1 Long-acting Reversible Contraceptives (LARCs) Industry Trends
8.2 Long-acting Reversible Contraceptives (LARCs) Market Drivers
8.3 Long-acting Reversible Contraceptives (LARCs) Market Challenges
8.4 Long-acting Reversible Contraceptives (LARCs) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
Merck
Cooper Companies
AbbVie(Allergan)
Yantai JiShengYaoXie
H & J Medical
HRA Pharma
Pregna
ASPIVIX
Shanghai Dahua Pharmaceuticals
Williams Medical Supplies
Laboratoire 7 MED
Durbin
Laboratoire Ccd
Prosan
OCON
List of Tables
 Table 1. Global Long-acting Reversible Contraceptives (LARCs) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Long-acting Reversible Contraceptives (LARCs) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Long-acting Reversible Contraceptives (LARCs) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Long-acting Reversible Contraceptives (LARCs) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Long-acting Reversible Contraceptives (LARCs), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Long-acting Reversible Contraceptives (LARCs), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Long-acting Reversible Contraceptives (LARCs), Product Type & Application
 Table 12. Global Key Manufacturers of Long-acting Reversible Contraceptives (LARCs), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Long-acting Reversible Contraceptives (LARCs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Reversible Contraceptives (LARCs) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Long-acting Reversible Contraceptives (LARCs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2020-2025)
 Table 19. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2026-2031)
 Table 21. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2020-2025)
 Table 23. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2026-2031)
 Table 25. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units) by Type (2020-2025)
 Table 51. Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units) by Type (2026-2031)
 Table 52. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2020-2025)
 Table 53. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2026-2031)
 Table 54. Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2020-2025)
 Table 57. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2026-2031)
 Table 58. Global Long-acting Reversible Contraceptives (LARCs) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Long-acting Reversible Contraceptives (LARCs) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units) by Application (2020-2025)
 Table 61. Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units) by Application (2026-2031)
 Table 62. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2020-2025)
 Table 63. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2026-2031)
 Table 64. Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2020-2025)
 Table 67. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2026-2031)
 Table 68. Global Long-acting Reversible Contraceptives (LARCs) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Long-acting Reversible Contraceptives (LARCs) Price (US$/Unit) by Application (2026-2031)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer Long-acting Reversible Contraceptives (LARCs) Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck Long-acting Reversible Contraceptives (LARCs) Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Cooper Companies Company Information
 Table 81. Cooper Companies Description and Business Overview
 Table 82. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product
 Table 84. Cooper Companies Recent Developments/Updates
 Table 85. AbbVie Allergan Company Information
 Table 86. AbbVie Allergan Description and Business Overview
 Table 87. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product
 Table 89. AbbVie Allergan Recent Developments/Updates
 Table 90. Yantai JiShengYaoXie Company Information
 Table 91. Yantai JiShengYaoXie Description and Business Overview
 Table 92. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product
 Table 94. Yantai JiShengYaoXie Recent Developments/Updates
 Table 95. H & J Medical Company Information
 Table 96. H & J Medical Description and Business Overview
 Table 97. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product
 Table 99. H & J Medical Recent Developments/Updates
 Table 100. HRA Pharma Company Information
 Table 101. HRA Pharma Description and Business Overview
 Table 102. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product
 Table 104. HRA Pharma Recent Developments/Updates
 Table 105. Pregna Company Information
 Table 106. Pregna Description and Business Overview
 Table 107. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Pregna Long-acting Reversible Contraceptives (LARCs) Product
 Table 109. Pregna Recent Developments/Updates
 Table 110. ASPIVIX Company Information
 Table 111. ASPIVIX Description and Business Overview
 Table 112. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product
 Table 114. ASPIVIX Recent Developments/Updates
 Table 115. Shanghai Dahua Pharmaceuticals Company Information
 Table 116. Shanghai Dahua Pharmaceuticals Description and Business Overview
 Table 117. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product
 Table 119. Shanghai Dahua Pharmaceuticals Recent Developments/Updates
 Table 120. Williams Medical Supplies Company Information
 Table 121. Williams Medical Supplies Description and Business Overview
 Table 122. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product
 Table 124. Williams Medical Supplies Recent Developments/Updates
 Table 125. Laboratoire 7 MED Company Information
 Table 126. Laboratoire 7 MED Description and Business Overview
 Table 127. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product
 Table 129. Laboratoire 7 MED Recent Developments/Updates
 Table 130. Durbin Company Information
 Table 131. Durbin Description and Business Overview
 Table 132. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Durbin Long-acting Reversible Contraceptives (LARCs) Product
 Table 134. Durbin Recent Developments/Updates
 Table 135. Laboratoire CCD Company Information
 Table 136. Laboratoire CCD Description and Business Overview
 Table 137. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product
 Table 139. Laboratoire CCD Recent Developments/Updates
 Table 140. Prosan Company Information
 Table 141. Prosan Description and Business Overview
 Table 142. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Prosan Long-acting Reversible Contraceptives (LARCs) Product
 Table 144. Prosan Recent Developments/Updates
 Table 145. OCON Company Information
 Table 146. OCON Description and Business Overview
 Table 147. OCON Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. OCON Long-acting Reversible Contraceptives (LARCs) Product
 Table 149. OCON Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Long-acting Reversible Contraceptives (LARCs) Distributors List
 Table 153. Long-acting Reversible Contraceptives (LARCs) Customers List
 Table 154. Long-acting Reversible Contraceptives (LARCs) Market Trends
 Table 155. Long-acting Reversible Contraceptives (LARCs) Market Drivers
 Table 156. Long-acting Reversible Contraceptives (LARCs) Market Challenges
 Table 157. Long-acting Reversible Contraceptives (LARCs) Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Long-acting Reversible Contraceptives (LARCs)
 Figure 2. Global Long-acting Reversible Contraceptives (LARCs) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Long-acting Reversible Contraceptives (LARCs) Market Share by Type: 2024 & 2031
 Figure 4. Hormonal Intrauterine Devices Product Picture
 Figure 5. Copper Intrauterine Devices Product Picture
 Figure 6. Contraceptive Implants Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Long-acting Reversible Contraceptives (LARCs) Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Long-acting Reversible Contraceptives (LARCs) Market Share by Application: 2024 & 2031
 Figure 10. Age 20-24
 Figure 11. Age 25-34
 Figure 12. Age 35-44
 Figure 13. Others
 Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Long-acting Reversible Contraceptives (LARCs) Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Long-acting Reversible Contraceptives (LARCs) Sales (2020-2031) & (K Units)
 Figure 17. Global Long-acting Reversible Contraceptives (LARCs) Average Price (US$/Unit) & (2020-2031)
 Figure 18. Long-acting Reversible Contraceptives (LARCs) Report Years Considered
 Figure 19. Long-acting Reversible Contraceptives (LARCs) Sales Share by Manufacturers in 2024
 Figure 20. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Long-acting Reversible Contraceptives (LARCs) Players: Market Share by Revenue in Long-acting Reversible Contraceptives (LARCs) in 2024
 Figure 22. Long-acting Reversible Contraceptives (LARCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Long-acting Reversible Contraceptives (LARCs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2020-2031)
 Figure 25. North America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2020-2031)
 Figure 29. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2020-2031)
 Figure 37. China Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Long-acting Reversible Contraceptives (LARCs) by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Long-acting Reversible Contraceptives (LARCs) by Type (2020-2031)
 Figure 59. Global Long-acting Reversible Contraceptives (LARCs) Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Long-acting Reversible Contraceptives (LARCs) by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Long-acting Reversible Contraceptives (LARCs) by Application (2020-2031)
 Figure 62. Global Long-acting Reversible Contraceptives (LARCs) Price (US$/Unit) by Application (2020-2031)
 Figure 63. Long-acting Reversible Contraceptives (LARCs) Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Reversible Contraceptive Device Market Research Report 2025
Short Acting Contraceptives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Contraceptive Injectable Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Reversible Linear Solenoids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Long acting Injectable Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Long Acting Contraceptive Pills Market Research Report 2024
Birth Control Rings Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical lsolators Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Female Contraception Market Research Report 2024
RAS acting Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Reversible Propeller Market Research Report 2024
Renin Angiotensin System RAS Acting Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Latanoprost API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hormonal Contraceptive Implant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Long Acting Reversible Contraception LARC Market Research Report 2024
Global Long acting Contraceptive Injection Market Research Report 2024
Disposable Vaginal Dilators Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Long acting Anti HIV Drug Market Research Report 2024
Contraceptive Pills Market
Reusable Menstrual Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions